Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)
121.58
-4.60 (-3.65%)
Sep 5, 2025, 3:26 PM IST
NSE:LOTUSEYE Market Cap
NSE:LOTUSEYE has a market cap or net worth of 2.53 billion as of September 5, 2025. Its market cap has increased by 49.73% in one year.
Market Cap
2.53B
Enterprise Value
2.52B
Revenue
501.89M
Ranking
n/a
PE Ratio
382.69
Stock Price
121.58
Market Cap Chart
Since July 11, 2008, NSE:LOTUSEYE's market cap has increased from 741.39M to 2.53B, an increase of 241.04%. That is a compound annual growth rate of 7.41%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 5, 2025 | 2.53B | 82.44% |
Dec 31, 2024 | 1.39B | -20.10% |
Dec 29, 2023 | 1.73B | 8.95% |
Dec 30, 2022 | 1.59B | 47.50% |
Dec 31, 2021 | 1.08B | 56.56% |
Dec 31, 2020 | 689.40M | 46.36% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Sun Pharmaceutical Industries | 3,823.58B |
Divi's Laboratories | 1,628.25B |
Cipla | 1,254.77B |
Apollo Hospitals Enterprise | 1,122.17B |
Mankind Pharma | 1,060.34B |
Zydus Lifesciences | 1,020.17B |
Fortis Healthcare | 715.59B |
Alkem Laboratories | 633.87B |